An FDA-approved drug library screening identifies proteasome inhibitors as selective cytotoxic agents for angiosarcoma cells.
FDA 批准的药物库筛选发现蛋白酶体抑制剂是血管肉瘤细胞的选择性细胞毒性药物
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03016-2
Hsu Che-Yuan, Yanagi Teruki, Miyamoto Kodai, Otsuguro Satoko, Maenaka Katsumi, Nishihara Hiroshi, Nakamura Hideki, Takahashi Kenzo, Ujiie Hideyuki